Client FYI: How Facebook Changes are Impacting Pharma Marketers

This POV continually updates as relevant news hits. Executive Summary: With recent Facebook news, we want to assure clients that…

Gen Alpha: What Marketers Should Know About How Today’s Children Use Technology

Today’s 6-year-olds enjoy coloring and blocks. They can also probably use a tablet and its corresponding apps better than most adults. They speak to Amazon’s Alexa as if she is a close friend and when they need information, the first place they turn is the Internet (rather than a parent).

Why Mobile Customization is Key in Pharma Advertising

Most healthcare brands are now making mobile a priority. Recently there are even more reasons to do so, as well as ways to make this channel work for you to better engage HCP audiences. This POV will review why mobile is important for your brand and list ways to harness the medium for your brand goals.

Client FYI: How Facebook Changes are Impacting Pharma Marketers

No doubt you’ve been seeing a lot of news about Facebook this week, including stories about use of the company’s collected data and changes to the algorithm. This POV will address the latest news and how it may impact pharma marketers.

The Benefits and Possibilities of Pre-Roll for Pharma

When Google bought YouTube in 2006 its main focus was figuring out how to monetize the influx of all the videos being uploaded at an ever increasing rate on the platform. One of the methods for capitalizing on video consumption was display advertising, specifically pre-roll.

Facebook Debuts Messenger Ads: What Pharma Marketers Should Know

Background Facebook is expanding onto the home screen of its instant messaging app, Messenger. This new placement allows advertisers to reach…

AdBlocking, Search and Social Media – What Pharma Marketers Should do Today

Ad blocking has emerged as a central issue that will affect all publishers and agencies, providing unique challenges to overcome in 2017 and beyond. Working in the healthcare industry, the effects of ad blocking are especially magnified as our target audiences are more specialized and harder to reach than a traditional consumer media audience. And ad blocking doesn’t just affect digital display ads – there is an impact in search and social media as well. Through a series of discussions with media partners and reviews of published studies, CMI/Compas has identified common precursors to ad blocking and how some publishers are looking to combat it. This POV will explore the steps pharma marketers should be taking now to ensure their brands are minimally affected by ad blocking.

The Rise of Chatbots & Their Application In Pharma

Executive Summary Advances in technology, coupled with human demand and desire, intersect at points that we like to call “innovation.”…

Twitter Opens Its Advertising Doors with “Profiles Without Accounts” Test: What Does This Mean for Pharma Brands?

Background Advertising on various social platforms is nothing new. However, across these platforms, most require a brand or organization to…